115 related articles for article (PubMed ID: 16325281)
21. [Homocysteine and rheumatic disease].
Tinazzi I; Caramaschi P; Patuzzo G; Bambara LM; Biasi D
Recenti Prog Med; 2007 Dec; 98(12):646-52. PubMed ID: 18369042
[TBL] [Abstract][Full Text] [Related]
22. High dietary methionine intake increases the risk of acute coronary events in middle-aged men.
Virtanen JK; Voutilainen S; Rissanen TH; Happonen P; Mursu J; Laukkanen JA; Poulsen H; Lakka TA; Salonen JT
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):113-20. PubMed ID: 16487911
[TBL] [Abstract][Full Text] [Related]
23. The use of betaine in the treatment of elevated homocysteine.
Lawson-Yuen A; Levy HL
Mol Genet Metab; 2006 Jul; 88(3):201-7. PubMed ID: 16545978
[TBL] [Abstract][Full Text] [Related]
24. Lack of significant effects of methionine loading on endothelial function in elderly volunteers.
Hart SR; Mangoni AA; Swift CG; Jackson SH
Heart Lung Circ; 2006 Dec; 15(6):358-61. PubMed ID: 17046324
[TBL] [Abstract][Full Text] [Related]
25. Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow.
Tanriverdi H; Evrengul H; Enli Y; Kuru O; Seleci D; Tanriverdi S; Tuzun N; Kaftan HA; Karabulut N
Cardiology; 2007; 107(4):313-20. PubMed ID: 17264512
[TBL] [Abstract][Full Text] [Related]
26. Pro-thrombotic and pro-oxidant effects of diet-induced hyperhomocysteinemia.
Sauls DL; Arnold EK; Bell CW; Allen JC; Hoffman M
Thromb Res; 2007; 120(1):117-26. PubMed ID: 16979225
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of low and high dose folic acid on endothelial dysfunction in a murine model of mild hyperhomocysteinaemia.
Clarke ZL; Moat SJ; Miller AL; Randall MD; Lewis MJ; Lang D
Eur J Pharmacol; 2006 Dec; 551(1-3):92-7. PubMed ID: 17045583
[TBL] [Abstract][Full Text] [Related]
28. Homocysteinylation of metallothionein impairs intracellular redox homeostasis: the enemy within!
Colgan SM; Austin RC
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):8-11. PubMed ID: 17185621
[No Abstract] [Full Text] [Related]
29. Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice.
Noll C; Hamelet J; Matulewicz E; Paul JL; Delabar JM; Janel N
J Nutr Biochem; 2009 Aug; 20(8):586-96. PubMed ID: 18676137
[TBL] [Abstract][Full Text] [Related]
30. Hyperhomocysteinemia and thrombosis.
Lee R; Frenkel EP
Hematol Oncol Clin North Am; 2003 Feb; 17(1):85-102. PubMed ID: 12627664
[TBL] [Abstract][Full Text] [Related]
31. Antioxidant is a useful supportive agent for the treatment of coronary vasospasm with endothelial dysfunction in pig.
Onogi F; Saitoh S; Aikawa K; Ishibashi T; Maruyama Y
Coron Artery Dis; 2007 Mar; 18(2):133-40. PubMed ID: 17301605
[TBL] [Abstract][Full Text] [Related]
32. The case that hyperhomocysteinemia is a risk factor for coronary artery disease.
Murphy-Chutorian D; Alderman EL
Am J Cardiol; 1994 Apr; 73(9):705-7. PubMed ID: 8166071
[No Abstract] [Full Text] [Related]
33. Homocysteine metabolism in health and disease.
Gambhir JK
Indian Heart J; 2000; 52(7 Suppl):S9-15. PubMed ID: 11339444
[No Abstract] [Full Text] [Related]
34. The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats.
Kassab S; Garadah T; Abu-Hijleh M; Golbahar J; Senok S; Wazir J; Gumaa K
J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):206-11. PubMed ID: 17318789
[TBL] [Abstract][Full Text] [Related]
35. To C or not to C, that is the question!
Frei B
J Am Coll Cardiol; 2003 Jul; 42(2):253-5. PubMed ID: 12875760
[No Abstract] [Full Text] [Related]
36. Homocysteine and Parkinson's disease: a dangerous liaison?
Martignoni E; Tassorelli C; Nappi G; Zangaglia R; Pacchetti C; Blandini F
J Neurol Sci; 2007 Jun; 257(1-2):31-7. PubMed ID: 17336337
[TBL] [Abstract][Full Text] [Related]
37. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
Jakubowski H
J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
[TBL] [Abstract][Full Text] [Related]
38. [Homocysteinemia and coronary artery disease: a case-control study in a Tunisian population].
Souissi M; Feki M; Mourali S; Enneifer M; Omar S; Sanhaji H; Mechmeche R; Mebazaa A; Kaabachi N
Arch Mal Coeur Vaiss; 2006 Sep; 99(9):781-5. PubMed ID: 17067095
[TBL] [Abstract][Full Text] [Related]
39. Homocysteine and thrombosis: from basic science to clinical evidence.
Undas A; Brozek J; Szczeklik A
Thromb Haemost; 2005 Nov; 94(5):907-15. PubMed ID: 16363230
[TBL] [Abstract][Full Text] [Related]
40. [Effect of polymorphisms on key enzymes in homocysteine metabolism, on plasma homocysteine level and on coronary artery-disease risk in a Tunisian population].
Belkahla R; Omezzine A; Kchok K; Rebhi L; Ben Hadj Mbarek I; Rejeb J; Ben Rejeb N; Slimane N; Nabli N; Ben Abdelaziz A; Boughzala E; Bouslama A
Ann Cardiol Angeiol (Paris); 2008 Aug; 57(4):219-24. PubMed ID: 18620331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
